Antares Vision S p A : PR - Methods and Exercise Ratio Warrants
10/05/2020 | 01:30pm EST
METHODS AND EXERCISE RATIO OF ANTARES VISION WARRANTS
Travagliato (BS), 4 August 2020 - Antares Vision S.p.A. ("Antares Vision" or the "Company") informs that, pursuant to article 3 of the Regulation on "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation"1 and the "Warrants"), the Average Monthly Price for July 2020 is equal to Euro 11.0881 (source FactSet, Average Monthly Price calculated as arithmetic average of the official prices of Antares Vision S.p.A. ordinary shares of the trading days in July).
Therefore, since the Strike Price is equal to Euro 9.50 and the Subscription Price of the Conversion Shares is equal to Euro 0.10, the Exercise Ratio for August 2020 is equal to 0.1445.
Any request to exercise the Warrants must be submitted to the broker who is part of the centralised management system of Monte Titoli S.p.A. at which the Warrants are filed by the Last Trading Day in August 2020. The relevant Conversion Shares shall be made available by the Company for negotiation, through Monte Titoli S.p.A., on the settlement day following the end of August, 2020. The Conversion Shares will have the same dividends as ordinary shares at the effective date of Exercise of the Warrants.
The Subscription Price shall be wholly paid upon filing the exercise request on the Company's current account indicated below:
IT 24 F 03111 11236 000000005933
In all cases where, upon exercising the Warrants, one should be entitled to an odd number of Conversion Shares, the Warrant bearer shall be entitled to receive Conversion Shares to make up the immediately lower even number, and may not enforce any right with regard to the excess fractional part.
Upon submitting the request to exercise, the Warrant bearer shall acknowledge that the Conversion Shares assigned under the exercise of the Warrant have not been filed pursuant to the 1933 Securities Act as amended, in force in the United States of America.
Antares Vision also informs that during July, exercise requests were received totalling 361,497 Warrants. As a consequence, the Company issued 63,440 ordinary shares, for a total equivalent value of Euro 6,344.00 (of which Euro 6,191.74 as share premium), according to the methods set out by the Warrant Regulation.
1 The capitalised terms in this notice have the same meaning assigned in the Warrants Regulation.
Following the exercise of the Antares Vision warrants, the new share capital of Antares Vision is equal to Euro 143,037.12, divided into 58,112,942 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, none of which indicate the nominal value.
For any other information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvision.com - "Investors - Investor Relations - Warrants".
For further information
NOMINATED ADVISER AND SPECIALIST
ANTARES VISION S.P.A.
EQUITA SIM S.P.A.
VIA DEL FERRO, NO. 16
VIA FILIPPO TURATI, NO. 9
25039 - TRAVAGLIATO (BS)
20121 - MILAN
ALIOSCIA BERTO (CFO AND INVESTORRELATIONS
TEL.: +39 02 6204 1
TEL.: +39 030 72 83 500
IR TOP CONSULTING
VIA BIGLI, N. 19
20121 - MILAN
TEL.: +39 02 45473884
MARIA ANTONIETTA PIREDDU
A company listed on AIM Italia since 2019 through a business combination with ALP.I, a SPAC promoted by Mediobanca, Antares Vision guarantees the protection of products during their life cycle through inspection systems for quality control, tracking solutions to fight counterfeiting and control of the supply chain, smart data management for production efficiency and consumer engagement, in all the most demanding industrial sectors, from pharmaceuticals to biomedical devices, from food and beverage to cosmetics and fashion. Antares Vision has a presence in over 60 countries worldwide with comprehensive and flexible hardware and software solutions, and related services: it has 4 offices in Italy (Brescia, Parma, Piacenza and Latina), 12 foreign branches (Ireland, Germany , France , USA , Brazil , India, Russia and Hong Kong), 2 Innovation and Research centres (Italy and Ireland), in addition to a network of over 30 partners worldwide. With 20 years of experience in vision technologies, Antares Vision supplies 10 of the world's 20 leading pharmaceutical companies: over 25,000 inspection systems assure the product's safety and quality each day, while 6,500 inspection tests and over 3,500 serialisation lines installed all over the world guarantee the traceability of over 5 billion products throughout the entire distribution chain. With the aim to continue supporting its growth and development strategy, in 2019 investment agreements were perfected with T2 Software, a Brazilian company specialising in smart data management solutions, and Orobix, Italian leader in artificial intelligence services, in addition to acquiring 100% of FT System, a leader in checks and
inspection in the beverage sector. In April 2020, Antares Vision acquired 82.83% of Tradeticity, a Croatian company specialised in software management of advanced traceability processes, wheres on 30 July it acquired 100% of Convel, an Italian company specialising in automated inspection in the pharmaceutical industry. In 2019, Emidio Zorzella and Massimo Bonardi were awarded the Ernst & Young Entrepreneur of the Year Award for Innovation. www.antaresvision.com
Antares Vision S.p.A. published this content on 09 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 October 2020 17:29:01 UTC